BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martini V, D'Avanzo F, Maggiora PM, Varughese FM, Sica A, Gennari A. Oncolytic virotherapy: new weapon for breast cancer treatment. Ecancermedicalscience 2020;14:1149. [PMID: 33574894 DOI: 10.3332/ecancer.2020.1149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Gentile P. Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research. Biomedicines 2022;10:1179. [DOI: 10.3390/biomedicines10051179] [Reference Citation Analysis]
2 Mohammed D, Koehler M, Dumitru AC, Aravamudhan P, Sutherland DM, Dermody TS, Alsteens D. Altered Glycan Expression on Breast Cancer Cells Facilitates Infection by T3 Seroptype Oncolytic Reovirus. Nano Lett 2021;21:9720-8. [PMID: 34762801 DOI: 10.1021/acs.nanolett.1c03608] [Reference Citation Analysis]
3 Carter ME, Koch A, Lauer UM, Hartkopf AD. Clinical Trials of Oncolytic Viruses in Breast Cancer. Front Oncol 2021;11:803050. [PMID: 35004328 DOI: 10.3389/fonc.2021.803050] [Reference Citation Analysis]
4 Kwan A, Winder N, Muthana M. Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. Viruses 2021;13:1128. [PMID: 34208264 DOI: 10.3390/v13061128] [Cited by in F6Publishing: 1] [Reference Citation Analysis]